Development of tools to accelerate and advance modeling disease progression by Ruggiero, Steven MacRae








Submitted to the Faculty of the
Graduate College of
Oklahoma State University























• May ”Corvimae” R.
• And all of the wonderful people I’ve met through D&D
My family, who’s patience knows no limits:
• Parents: Holly and Louis Ruggiero
• Sister: Jean Ruggiero
• Grandparents: Graham and Jean Smith
My research group, who have learned alongside of me:




































• Hui Ling Yong
• Anya Zornes
All of the wonderful teachers and professors I met during my times at Union County
Magnet High School and Rowan University.
Special thanks to:
• Dr. Buchanan, who convinced me to study chemical engineering.
• Dr. Hesketh and Dr. Staehle, who convinced me to go to graduate school.
The medical professionals who helped me keep my life from falling apart due to
ADHD:
• Kara Grace, Shawna Moore, and the rest of the staff at CBSO
• Rachael Lawler
• Melissa Andrade and the rest of the staff at Andrade Medical Services
The funding sources that enabled the research presented here:
• Oklahoma Center for the Advancement of Science and Technology, Project
Number: HR17-057
• National Science Foundation, Award Number: 1845117
• National Institutes of Health, Project Number: R35GM133763
Acknowledgments reflect the views of the author and are not endorsed by
committee members or Oklahoma State University.
v
“The end of learning is the beginning of death.”
Eramir in Path of Exile by Grinding Gear Games
vi
Name: STEVEN MACRAE RUGGIERO
Date of Degree: Dec, 2020
Title of Study: DEVELOPMENT OF TOOLS TO ACCELERATE AND ADVANCE
MODELING DISEASE PROGRESSION
Major Field: CHEMICAL ENGINEERING
Abstract: Disease pathology emerges from complex interactions at multiple scales
including the cellular level, tissue level, and organ level. Multiscale modeling seeks
to capture emergent phenomena by coupling models of differing spatial and temporal
scales. Multiscale modeling is a powerful tool for modeling disease progression, but
this power comes at the cost of great complexity and development time. The primary
objective of this thesis is to develop tools that help make multiscale models in less
time. The tools developed in this work are a virtual kidney currently in development,
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Many human diseases cause physiological and morphological symptoms evident at
the tissue and organ level. However, these symptoms are the result of interactions
at the cellular level, which often involves signaling proteins moving between cells.
Furthermore, the actions of the cells are governed by biochemical networks contained
inside the cells. Due to this coupling of biological systems at differing spatial and
temporal scales, multiscale models are needed to properly predict the evolution of
diseases.
Computational modeling is useful for creating multiscale models for multiple rea-
sons. The most straight forward reason is that a computer can find a numerical
solution to a highly complex system of equations that have no analytical solution
or are time consuming to solve. Ordinary differential equations (ODEs) are good for
modeling biochemical networks inside cells. Biochemical network models are typically
complex enough to require a numerical solution. Additionally, computational model-
ing can employ methods such as agent based models (ABMs) that model individual
objects or agents that act using a set of rules. A major advantage offered by the va-
riety of models is that an appropriate model type can be matched to the model scale.
This feature makes ABMs useful for modeling tissues. Beyond the variety of model
types, computational modeling has a second advantage in that multiple models can
be coupled together, e.g., the results of a time step of one model can be fed directly
into another model. Multiscale models can be developed capitalizing on these two
advantages to construct accurate computational models of realistic systems. Despite
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these strengths, the biggest drawbacks of multiscale modeling are the complexity and
development time required.
1.1 The Significance of Study
The theme of generalizable open source code that makes developing multiscale models
easier and faster unifies the aims of this thesis.
1.1.1 Case I: A Generalizable Model
The first branch of this theme discusses the state of a comprehensive virtual kidney
under development. The motivation of the virtual kidney is to explore unanswered
questions about diabetic kidney disease (DKD) by starting from a healthy state and
simulating the kidney’s progression to a diseased state. Through modular code de-
sign, the disease mechanisms specific to DKD can be swapped out for mechanisms
associated with other kidney diseases. As a result, one of the long term goals of the
virtual kidney is to serve as a framework that can be generalized to other diseases.
Chapter II presents Aim I of this thesis: Establishing the Virtual Kidney.
1.1.2 Case II: Generalized Tools
The second branch is the generalization of methods used to solve problems encoun-
tered in Aim I. These problems i) are encountered by other researchers that develop
systems biology models, ii) have existing solutions that are insufficient for our needs,
and iii) leave a gap in solutions that represents a niche to be filled.
Systems Biology Markup Language (SBML) [1] is a popular standard for storing
biochemical models, with thousands available from the BioModels database [2, 3].
While developing the virtual kidney, I explored the possibility of coupling SBML
models into our simulations. Multiple converters exist that turn SBML into a variety
of programming and modeling languages, but Python [4] is not one of the options
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available [5]. Other Python modules that handle SBML models do not suit the needs
of the project. Given the use of Python as the programming language of choice in Aim
I, its rising use in computational science, and a lack of SBML to Python converters,
I created an open source SBML to Python converter. Chapter III presents Aim II of
this thesis: SBMLtoODEpy, An Open Source Systems Biology Markup Language to
Python Converter.
Early work on the virtual kidney focused on examining the effects of cellular
dysfunction at the level of an entire glomerulus. Glomeruli are the initial sites of urine
filtration in the kidney and suffer severe damage in a DKD patient. Due to variance
in the geometry of cross sections in a single glomerulus, we wanted to produce a
wide variety of geometries that represent the glomeruli. The methodology presented
in Aim III incorporates the concepts used in game development to create a highly
flexible algorithm for generating tissue geometry. Chapter IV presents Aim III of this
thesis: Procedural Generation Methods in Tissue Simulation.
Chapter V discusses the future work needed to further these projects beyond their
current state.
1.2 Publications Outside of Thesis Scope
I have authored two publications that have not been included in this thesis. The
primary reason for their exclusion is that the work was either not generalizable or did
not use novel computational techniques.
1.2.1 Mathematical Modeling of Tuberculosis Granuloma Activation
The first paper I was first author on [6] was written by Dr. Minu Pilvankar, Dr.
Ford Versypt, and me. The work discussed in the paper added novel equations to a
preexisting model of tuberculosis (TB) [7]. These equations modeled the regulation
of matrix metalloproteinase-1 (MMP-1), collagen buildup, and bacterial leakage in
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a TB granuloma. MMP-1, commonly referred to as collagenase, breaks down the
collagen membrane of the granuloma. As the membrane deteriorates, containment of
TB bacteria inside the granuloma fails, leading to an active infection.
My contributions to this work were in replicating the model from [7] and imple-
menting the new equations into the model. Recreating the original model proved
to be a difficult task. With 13 ordinary differential equations (ODEs), searching for
even a single error proved to be arduous. This was compounded by the fact that the
original model was not available. Once satisfactory implementation of the original
model was completed, the new portion of the model was added into the code.
The other aspect of my work on this project was developing scripts to analyze
the model. Our paper had several virtual experiments including a local sensitivity
analysis, a gene deletion experiment, and an exploration of the effect of a key variable
added to the model. The local sensitivity analysis searched for the model parameters
that had the greatest effect on TB leakage out of the granuloma by running the model
with a single adjusted parameter. This run was then compared to the results of a
basis parameter set to quantify the effect of the adjusted parameter. Gene deletion
provided insight into how a single part of biological system behaves with that part
removed. For the gene deletion experiments, one of the ODEs in the model was set
to 0, and the difference in model behavior was used to infer the role of the variable
removed. Parameter kC is the rate constant for the degredation of collagen. This
parameter was specifically targeted for analysis because it was the novel parameter
that had the greatest impact on bacterial leakage and was easy to use in tuning the
rate of bacterial leakage when studying the effect of leakage on other model variables
[6].
While the additions to the TB model were novel, the scripts developed for the
project did not solve any new problems from a programmatic perspective. Numerical
methods for solving ODE models is one of the oldest and most explored compuational
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methods, and the virtual experiments were based on analyses of other models. While
this publication falls outside of the scope of this thesis, the experience developing the
code for the ODE model and its analysis gave insight used in Aim II. How SBML-
toODEpy generates Python model implementations was directly influenced by the
needs I had as a researcher during this project.
1.2.2 Building a MATLAB Graphical User Interface to Solve Ordinary
Differential Equations as a Final Project for an Interdisciplinary
Elective Course on Numerical Computing.
The second paper I helped author [8] was written by Jianan Zhao, Dr. Ford Versypt,
and me. In this publication, we detailed a class project of developing a MATLAB [9]
graphical user interface (GUI) for solving a system of ODEs. The project served as
a capstone for an applied numerical computing class. Topics covered in the course
included Python and MATLAB basics, parameter fitting, GUIs, and solving ODEs.
The project required the MATLAB program to have a GUI and solve an arbitrary
system of ODEs, which meant the project required mastery of most of the concepts
covered in the class.
The project requirements stated that students can expect the equations to be
entered into their program in an order such that each equation is only dependent on
previous equations. This kept the complexity of the project down to a manageable
level. My project submission was inspired by Polymath [10], a software program
for common numerical methods used in chemical engineering education. One of the
features of Polymath is that the equations can be entered in an arbitrary order, and
the program will sort out the order to solve the equations. Due to a combination
of ambition and sheer stubbornness, I wanted my submission to handle equations
entered in an arbitrary order. This added back in the complexity Dr. Ford Versypt
tried to keep out of the project.
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Sorting the equations took two steps: parsing and then reordering the equations.
Parsing the equations made use of regular expressions. Regular expressions are used
to define text patterns. For this project, I defined patterns that I expected a user
would enter for their equations. The regular expressions identified variable names,
differentials, functions, and operators from entered text. When the parsing function
finds a matching pattern, it breaks off the matching portion of text, interprets it, and
then recursively calls itself with the remaining text as input. The final output of the
function is an array that has the dependent variable, independent variable for ODEs,
equation type, and a tree representing the variables and order of operations of the
right hand side of the equation [8].
Each variable defined by an ODE has an associated initial value. Therefore, the
columns associated with variables defined in ODEs are zeroed out immediately. Then
an equation with a single 1 in its row is picked, and the column of the variable is zeroed
out. This process repeats until no changes occur in the matrix after an iteration. If
all elements are zero, the equations are properly defined, and the order of the rows is
a valid equation order [8].
Like the TB model discussed in Section 1.2.1, the resulting software pushes no
boundaries; it was an educational contribution, and the experience I gained was
invaluable in developing Aim II. The most important module in SBMLtoODEpy is
the function that generates code from model elements. In that function I rewrote the
Gaussian elimination algorithm I developed in [8] to place Assignment Rules in
the correct order in Aim II.
1.3 Research Objectives
Aim I: Establishing the Virtual Kidney.
• Task 1 - Incorporate a partial differential equations (PDEs) solver and ABM
simulator.
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• Task 2 - Add ability to incorporate ODEs generated from the results of Aim II.
• Task 3 - Develop PDEs to solve the transport of signaling proteins in the
glomerulus.
Aim II: SBMLtoODEpy, An Open Source Systems Biology Markup
Language to Python Converter.
• Task 1 - Interpret SBML files to produce intermediate text files.
• Task 2 - Generate Python models.
• Task 3 - Represent biochemical networks in mesangial cells, podocytes, and
epithelial cells with ODEs.
Aim III: Procedural Generation Methods in Tissue Simulation.
• Task 1 - Develop a algorithm to generate simulation geometry.
• Task 2 - Parameterize the function to enable creation of varied geometries.
• Task 3 - Outline generalizing the algorithm.
1.4 Potential Impact
The majority of the work presented in this thesis is directly connected to the virtual
kidney project. The first aim discusses development of the virtual kidney itself. The
second and third aims solve problems encountered in the project. The most immediate
and direct impacts of the aims of this thesis will be on DKD research; already Aim
II was used to create the Python implementations of podocyte and mesangial cell
models used in Aim I.
It is my hope that the aims of this thesis will be useful beyond the context of
DKD research. As discussed in Section 1.1, I see the possibility for a wider impact
of my work. Development of the virtual kidney will continue beyond my tenure in
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Dr. Ford Versypt’s lab, and the contributions I have already made will continue to
shape its development. The success of Aim I will be measured by the time saved in
further development of the virtual kidney and the applicability of my contributions to
other forms of kidney research. As Python grows in use by computational modelers,
the demand for research oriented Python packages will grow. While other SBML
tools exist for Python, SBMLtoODEpy targets a niche unfilled by other packages
at the time of writing. The success of Aim II will be measured by the flexibility
that generated models provides to other researchers. Procedural generation offers a
way to produce a robust variety of geometries with minimal researcher time. The
methodology in Aim III incorporates an idea from outside of systems biology in an
attempt to improve it. The success of Aim III will be measured by its impact on
other researchers’ ability to develop simulation geometries.
To me, no success is greater than my work benefiting other researchers.
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CHAPTER II
Establishing the Virtual Kidney
2.1 Introduction
2.1.1 Motivation
Diabetic kidney disease (DKD) is the most common form of end stage renal disease
[11, 12]. According to the 2019 report published by the United States Renal Data
System, 46.9% of patients receiving hemodialysis, peritoneal dialysis, or a transplant
for end stage renal disease had diabetes as the primary cause [13]. Its prevalence in the
US population is increasing due to increasing prevalence of diabetes [12]. However,
DKD is not just a US health issue; DKD incidence has been rising around the globe
[11].
The glomerular tissues are the tissues key to understanding DKD. The glomeruli
(plural of glomerulus) are structures in the kidney that filter waste products from the
bloodstream. Figure 2.1.1 shows the structure and cross section of a glomerulus. Of
note are mesangial cells and podocytes. The mesangium, comprised of the mesangial
cells and their extracellular matrix (ECM), are located inside clusters of capillaries
and provide structure for the glomerular tuft [14]. Podocytes envelope the capillaries
with interwoven protrusions known as foot processes. The foot processes are linked via
a protein mesh to create a size-exclusion filtration barrier known as the slit diaphragm
or slit membrane [15].
Under chronically elevated glucose, the biochemistry inside the mesangial cells
changes and leads to several structural changes [16]. The earliest structural changes
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Figure 2.1: Insert shows a glomerulus and the magnified view shows a cross sectional
slice of a glomerulus [14]
are the thickening of the glomerular, capilliary, and tubular basement membranes.
The next set are mesangial swelling, breaking of linkages between podocytes, and
loss of endothelial fenestrations [11]. The process of podocytes losing the interdig-
itating pattern of their foot processes is known as effacement, which leaves gaps in
the filtration barrier [17, 18]. Parallel to effacement is podocyte dedifferentiation.
When podocytes dedifferentiate, they lose the ability to form the linkages between
foot processes, which in turn further complicates maintenance of the slit diaphram.
The net result is that due to the loss of podocytes, proteins are able to penetrate the
glomerular filtration barrier and pass into the urine, termed proteinuria [18].
The two primary metrics used in diagnosing DKD are the estimated glomerular
filtration rate (eGFR) and the presence of albumen in the urine, also known as albu-
minuria [11, 19]. Both measures have problems associated due to uncertainty inherent
to producing the measure. The uncertainty with measuring eGFR comes from a high
degree of imprecision in the equations used in calculating eGFR. With measuring
albuminuria, the uncertainty lies in the day to day variation of the concentration of
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albumin present in a patient’s urine [19]. Not only is there uncertainty in the mea-
sures themselves, but also in the relationship between these measures and tissue level
damage [11, 19]. Ultimately, we lack a diagnostic tool that is able to detect DKD
early enough and reliably enough [20].
Various modeling, data analysis, and computational techniques have been em-
ployed in the field of systems biology to gain a better understanding of DKD. These
run the range from organ and multiorgan models, data analysis of data sets produced
by omic (genomic, epigenomic, proteomic, etc.) experiments, and tissue level models
focusing on the kidney itself [20]. These tissue level models have considered transport
in the kidney [21, 22, 23, 24, 25, 26], the efficacy of the kidney as a filter [27, 28, 29],
renal bloodflow [30, 31, 32, 33], and the progression of renal interstitial fibrosis [34].
One of the open questions on DKD we seek to answer is “What are the interactions
and temporal relationships among podocyte, mesangial, and endothelial cell injuries”
[20]?
2.1.2 The Virtual Kidney
The work presented in this chapter is the development of a model that seeks to
answer questions about how DKD progression occurs. The overarching goal of the
larger project in our lab is to develop a comprehensive virtual kidney. The conceptual
model used in developing the virtual kidney is shown in Figure 2.2. This conceptual
model leans heavily on two concepts multi-scale modeling and modular code design.
Multiscale modeling analyzes interacting processes that lead to emergent behav-
ior. For example, changes in behavior at the cellular level can cascade into structural
changes at the tissue and organ level. Central to the development of multiscale models
is that an appropriate model type can be matched to the scale of a process. Figure 2.3
shows different types of models and the biological scales they are effective at. Agent
based models (ABMs) are useful for modeling tissues, including the interaction be-
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Figure 2.2: The conceptual model used to develop the virtual kidney. Each of the
three model types used focuses on a set of phenomena. The scale of the partial
differential equations and the agent based model are the same, but the processes
they model can not effectively be modeled by the other. The ordinary differential
equations scale is that of a single cell. Each model is separate from each other, and
coupling the models together is done using each model’s interface.
tween swelling mesangium and podocyte effacement. Ordinary differential equations
(ODEs) on the other hand are better for modeling biochemical networks inside cells
[35]. Multiscale modeling requires coupling together multiple models. For example,
the results of an ODE model representing the biochemical networks of a cell can be
coupled to the behavior of an agent representing a cell in an ABM.
In modular software design, pieces of a software system that can operate indepen-
dently should have their implementation separate from the rest of the system, and
communicate using a standardized interface [36]. For a module containing an ODE
model, the functions that compute differentials and the algorithm used to integrate
the equations are part of that model’s implementation. If an ABM coupled to and
ODE model is independent of how the ODEs are solved, the interface of the ODE
model contains two parts: a function that signals the ODE model to step forward
12
Figure 2.3: Recommended guidelines for appropriate modeling technique based on
system scale [35]. While some modeling types may be used in more than one scale,
no single type covers the range from the pathway and signaling scale to the tissue
scale. Bridging this gap may be done by coupling multiple models together.
in time, and the object members that contain the model solution at the new time.
Improvements or complete redesigns of how an ODE model is solved can be made
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without considering how other modules are implemented. Or more abstractly, im-
plementation changes that do not affect the module’s interface can be made without
impacting how other modules function [36].
Modular design principles not only make coupling the models of different scales
together easier, they allow generalizing the virtual kidney beyond analysis of DKD.
The virtual kidney concept seeks to start from a healthy kidney state and progress
towards a diseased state. The diseased state modeled depends on the mechanisms
of disease progression implemented in each model. Standardized interfacing enables
incorporating models of other types of kidney disease with minimal researcher time
invested.
The main factors that drive DKD progression that the model considers are the
effects of hyperglycemia on the biochemistry within glomerular cells, how dysreg-
ulation in cells propagate to other cells through signaling proteins, and the tissue
level damage that emerges from these cells. The biochemistry of interest has two
parts. The first is the renin-angiotensin system (RAS) local to the podocytes and
mesangial cells [37, 38]. The RAS model captures the dynamics of angiotensino-
gen (AGT), angiotensin-I (ANG-I), angiotensin-II (ANG-II), and renin. The second
is upregulation of transforming growth factor beta 1 (TGF-β1) in mesangial cells
that results from dysregulation of the RAS [39, 40, 41, 42, 43]. Elevated levels of
TGF-β1 cause inhibition of matrix metalloproteinase-2 (MMP-2) [44]. MMP-2 is
responsible for breaking down the extracellular matrix in the mesangium. Two ODE
models were developed to capture the effects of glucose on the biochemical networks
involved. One model was for the podocytes ((1.1), (1.2), (1.4), and (1.5) in Appendix
A), and the other captured the mesangial cells ((1.1), (1.2), (1.4), (1.5), (1.9), and
(1.12) in Appendix A). These models were developed by my labmates Dr. Minu
Pilvankar in her PhD studies [45, 46, 47] and Ashlea Sartin in her undergraduate
research project. The ODE models for the podocytes and mesangial cells that they
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developed for our collaborative project are summarized along with their associated
parameters in Appendix A. These models are coupled to a solute transport model to
capture intercelluar signaling and a tissue structure model to capture emerging tissue
damage.
2.1.3 Software Used
CompuCell3D was used to develop the tissue structure model used in this project. At
its core, CompuCell3D uses the Glazier-Graner-Hogeweg (GGH) model to drive time
evolution of a simulation [48]. The GGH model was developed as an extension of the
Potts model [49, 50]. Classically, the Potts model examines a system of spin states in
a lattice. The lattice is subdivided by a regular shape, for example into squares, with
a spin state contained in each square. The number of unique spin states available
depends on the system; a Potts model can be made for a system with an arbitrary
number of available spin states. The spin states interact with neighbors, and each
interaction has an energy associated with it based on the states of the two spins. The
energy of the entire system is the sum of all interactions [51, 52].
In the GGH model, the concept of spin states is equated to cell indexes. Each
unique spin state is directly associated with a cell, and a cell occupies the areas
of the lattice containing that spin state. The next conceptual modification is the
introduction of cell types. Each cell has a cell type, and the energy calculations are
based on cell types instead of spin states [49, 50, 48]. It is important to note that in
the conceptual framework of the GGH model, the effective energies calculated do not
represent physical energy [48].




Contact energy between cells +
∑
Volume constraint energy. (2.1)
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The first sum is iterated over all interfaces of the lattice. J is an NxN matrix
containing the contact energies for each possible pairing of N cell types and is indexed














same cell. The Kronecker delta is
δ(i, j) =
 0 : i 6= j1 : i = j (2.3)









The second sum is iterated over all cells in the simulation. The parameter λvol(σ) is
the resistance of the cell, σ, to deviation from the cell’s target volume, Vt(σ). The
cell’s energy contribution is proportional to the square of the difference between its
volume, ν(σ), and its target volume [48].
On top of this style of energy calculation, CompuCell3D uses a Monte Carlo
method to move a model forward in time. Despite Monte Carlo steps traditionally
having no connection to time stepping, GGH models have empirically shown to have
Monte Carlo steps directly proportional to time steps in biological applications [48].
The random move used in the Monte Carlo method is spin flipping. CompuCell3D
selects a lattice site and one of its neighbors. Provided that the sites are occupied by
different cells, the neighbor is set to be occupied by the cell in the first site chosen.
The energy difference between the two states, ∆H, is computed and used to calculate
a probability of acceptance [48]. The acceptance function used is the Boltzmann
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acceptance function [48, 53]
P (∆H) =
 1 : ∆H ≤ 0e−∆HTm : ∆H > 0 (2.4)
where Tm is a parameter that acts to modify the rate of acceptance of a Monte Carlo
step [48]. While Tm plays a functionally similar role to temperature, it does not
represent the actual temperature in a model. Additionally, since both ∆H and Tm
are in arbitrary units, this acceptance function can neglect the Boltzmann constant,
which relates temperature and energy. A single Monte Carlo step attempts a random
spin flip and accepts or rejects the result a number of times equal to the total number
of lattice sites [48].
CompuCell3D’s energy calculations are not limited to just contact energy and
volume. It supports energy terms that can drive chemotaxis, apply surface area
constraints to cells, create links that represent physical connections between cells,
and more [54]. This model creates a changing geometry that is not captured by
multiphysics or computational fluid dynamics software. Further, CompuCell3D allows
users to incorporate Python [4] scripts into their simulations using an application
programming interface [48, 55]. This enables coupling a tissue model developed in
CompuCell3D with an arbitrary Python based model. While CompuCell3D does
have PDE solvers built in, they primarily use the forward Euler method [54]. For this
project, the forward Euler method does not provide enough numerical stability or
accuracy when handling convection terms. Due to these issues, the transport model
was developed using the partial differential equation (PDE) package FyPi [56].
FiPy is a Python based PDE solver that uses the finite volume method (FVM) to
solve equations of the form
∂ρΦ
∂t
− [∇ · (Di∇)]n Φ−∇ · (uΦ)− SΦ = 0 (2.5)
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where Φ is the solution variable and the terms from left to right are the transient
term, the diffusion term, convection, and source terms. In the transient term, ρ is
an arbitrary rate factor. In the diffusion term, Di, is the diffusivity of Φ and can
be either a scalar if the diffusivity is isotropic or a matrix in anisotropic cases. The
variable n is the order of the diffusion term. In the convection term, u is a vector
field of a velocity moving Φ. The last term SΦ abstractly represents processes like
reaction or decay that directly add or remove Φ at a location. SΦ can be a function
of Φ. FiPy provides the ability to solve equations like (2.5) by implementing the four
terms, meshes, variables, and solvers as Python classes [56]. This means that FiPy
has done the majority of the low level coding needed to set up and solve PDEs. The
first major advantage of FyPi is that it allows for the rapid development of scripts to
solve PDEs without the user getting caught up in the difficult work of implementing
the FVM. Since FiPy was developed with the approach of solving arbitrary equations,
the resulting Python package is extremely flexible. FiPy offers support for more types
of terms than the ones that appear in (2.5) that are easily added into an equation.
The classes provided by FiPy are flexible in a way that allows the same problem to be
solved in multiple ways, and these classes support coefficients that vary over space,
time, or with respect to another solution variable in a system of PDEs [57].
2.2 Agent Based Model
While we are interested in how cellular dysregulation propagates to tissue damage at
the scale of the whole glomerulus, we focused on a smaller scale to maintain a finer
resolution. Here we investigated a region just large enough to capture the effects of
the bloodstream glucose on the mesangial cells, podocytes, and glomerular basement
membrane. To this end, the glomerular tissue simulation models a small section of
the mesangium adjacent to a capillary. The initial conditions for this simulation are
visualized in Figure 2.4, and the measurements used to design the geometry are in
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Table 2.1.
Figure 2.4: Visualization of the tissue model after the first time step. CompuCell3D
produces the first image of the simulation after the first Monte Carlo step rather
than at the initial condition. The yellow cells represent the mesangium, the blue
cells represent the glomerular basement membrane, and the light and dark green
cells represent the foot processes. The light green portions of the foot processes
serve as anchors for the links between the foot processes. The black area is the
medium, which represents the Bowman’s space. The numbered labels correspond to
the boundaries of the domain.
Table 2.1: Measurements used in designing the initial conditions of
the CompuCell3D simulation. A basis of 0.02 µm per pixel length is
used in our simulations.
Parameter Value Units Pixel Lengths Sources
Mesangium width 5 µm 2551 [23]
Mesangium height 0.5 µm 25 [23]
GBM thickness 0.1 µm 5 [23, 58]
Foot process width 0.29 µm 15 [59]
Foot process height 0.3 µm 15 [58]
Nephrin width 390 Å 2 [27, 60]
Simulation space height - - 100 -
1 250 pixel lengths would capture this measurement better, but 255
was chosen because it is an integer multiple of 17 (foot process
width + nephrin width).
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2.3 Solute Transport Model
The concentration fields in the simulation are governed by
dCi
dt
= ∇ · [Di0KDi(x, y)]∇Ci −∇ · [~v(x, y)KCi(x, y)]Ci + fi(~p[x, y], ~C) (2.6)
where Ci is the concentration of species i, Di0 is the diffusivity of species i through
the blood plasma, KD is diffusive hindrance due to transport through porous media,
~v is the velocity field of the blood plasma, KC is the convective hindrance of porous
media, fi is a function that solves the biochemical model developed for podocyte
cells, ~p is the parameters of the biochemical model, and ~C is the concentrations
of all species. The generation and consumption of signaling proteins for each foot
process was adapted from the podocyte model described in Appendix A. Inside of the
podocytes, ~p contains the appropriate values for the podocyte model. Outside of the
cells, the value for each parameter is set to zero, aside from parameters that appear
in denominators to avoid divide by zero errors.
Boundary 1 (Figure 2.4) is at the bottom of the mesangium and is assumes to be
the interface at an mesangial cell membrane. For glucose, it is assumed to be a no flux
boundary. For the other solutes, the concentrations at this boundary are determined
by the mesangial cell model. A copy of the mesangial cell model (Appendix A) is
instantiated for each face along the bottom. The x dimension is 255 pixels long. This
means a total of 255 copies of the mesangial cell model. The glucose concentration for
each model is sampled from the center of the pixel adjacent to the model’s face. For
each time step, the ODE models are progressed forward before solving the PDEs. At
each face, the concentration of the non-glucose solutes are set to the corresponding
instance of the mesangial cell model. Boundary 2 is at the left side of the mesangium
where the mesangium contacts a capillary. The concentration at the capillary bound-
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ary is set to bloodstream concentrations for all species. Currently the bloodstream
concentrations for solutes other than glucose are assumed to be governed by the same
model used for the mesangial cells. This assumption is unrealistic but usable to show
the model’s current functionality. The right side of the mesangium and both sides of
the GBM are boundaries 3, 4, and 5. These boundaries are set as no flux conditions.
While these boundaries are symmetry boundaries, we assume that any local fluxes
are parallel to the boundaries. Boundaries 6, 7, and 8 for the Bowman’s space are
set to ~n · ∇Ci, where ~n is the unit vector normal to the face. When the gradient at
the boundary is explicitly constrained, FiPy treats the boundary as an inlet or outlet
condition as appropriate for the convection terms [57].
Currently, the parameters for energy calculations are arbitrarily chosen. Our end
goal is to couple the transport and biochemical models with the parameters used for
effective energy calculations in CompuCell3D. The effective energy parameters drive
the behavior of the cells and we hypothesize that the coupling will be able to capture
the physiological changes of tissues due to dysregulation of biochemical networks.
Here, the scope is limited to looking at the chemical crosstalk and transport between
cells. In addition to serving as a basis for future inquiry, CompuCell3D is used to
represent the cells as physical objects in our simulation space and to visualize solute
concentration fields.





where kB is the Boltzmann constant, T is the temperature in Kelvin, µsolvent is the
viscosity of the bulk fluid, and ai is the hydrodynamic radius of the molecule. For the
other solutes, their D0 and ai were computed using HYDROPRO [61]. HYDROPRO
starts its evaluation of hydrodynamic properties by constructing a geometric model
from a protein structure. The geometric model is used to simulate the interactions
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between the protein and the solvent [61]. HYDROPRO requires the partial specific
volume of the protein as input. This measure is not readily available for the species in
our models, so it was assumed to be equal to the inverse of density. Data on density
are not readily available either, so the density was approximated from the correlation
[62]
ρ = 1.410 + 0.145e−
MW
13 (2.8)
where ρ is the density in g cm−3, and MW is the molecular weight in kDa. The values
of Di0 and ai used in the simulation are in Table 2.2.
Table 2.2: Values of Di0 and ai used for each species.
The value of a and method for computing D0 of glu-
cose are from [23]. For the other species, [62] and [61]
were used to compute D0. The sources for the protein
structure files are listed.
Species D0 a Sources
Glucose 853 µm2 s−1 3.8× 10−4 µm [23]
ANG-I 297 µm2 s−1 1.09× 10−3 µm [63]
ANG-II 307 µm2 s−1 1.05× 10−3 µm [63]
AGT 103 µm2 s−1 3.15× 10−3 µm [64]
Renin 91.1 µm2 s−1 3.22× 10−3 µm [65]
TGF-β1 121 µm2 s−1 3.62× 10−3 µm [66]
MMP-2 89.5 µm2 s−1 2.67× 10−3 µm [67]
The value of KD depends on the medium through which a solute diffuses through
and the hydrodynamic radius of the solute. Three media are present in the simulation:
the mesangium, glomerular basement membrane, and the Bowman’s space. The
Bowman’s space is not modeled as a porous media, therefore KD is 1 in the Bowman’s
space. In the mesangium and glomerular basement membrane, each species has a


















where φ is the fraction of volume occupied by fibers in the matrix and λi is the ratio
of solute radius to fiber radius [23]. For regions occupied by the foot processes, Di
is set to 0 inside of the foot processes except for the pixels where the foot process
contact the glomerular basement membrane. This approximates foot processes only
secreting into and uptaking from the GBM.
KC is the convective hindrance caused by a porous media on the solute [68]. The
results presented in this chapter uses the same assumptions as the model of [23];
the mesangium has no effect on convection, and the glomerular basement membrane
is a perfect filter. This equates to KD = 1 in the mesangium and KD = 0 in the
glomerular basement membrane.
2.4 Computational Fluid Dynamics Simulation
The velocity field in (2.6) is solved using a 2D computational fluid dynamics simu-
lation in Star-CCM+ [69] that models the flow through the mesangium, glomerular
basement membrane, and Bowman’s space. The geometry used in this simulation is
shown in Figure 2.5. The properties of the porous media used in the simulation are
the same as the work of Hunt et al. [23].
The mesangium and glomerular basement membranes were modeled as porous
media, and the flow through the Bowman’s space was modeled as laminar flow. For
flow through porous media, pressure and velocity are related using
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Figure 2.5: Geometry used in the computational fluid dynamics simulation to rep-
resent the combined mesangium, glomerular basement, and Bowman’s space. The
top image shows the full scale of the geometry, and the bottom is a close up of the
mesangium and glomerular basment membrane in the computational fluid dynamics
simulation. The voids represent the foot processes, which block flow.
−∇P = µsolvent
kp
~vs + bexpρ|~vs|~vs (2.12)
where P is the pressure, µsolvent is the viscosity of the fluid, kp is the permeability,
~vs is the superficial velocity, and ρ is the density of the fluid. The term bexp is an
experimentally determined term used to capture second order dependence on velocity
[69]. For our simulations bexp was set to 0, which reduces (2.12) to Darcy’s law. Values




(− lnφ− 0.931) (2.13)
where r is the radius of the fibers of the porous media [23].
This simulation deviates from [23] in two key ways. We assume that the foot
processes block fluid flow, only allowing fluid to escape out of the glomerular basement
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membrane in narrow channels. The second difference is that instead of modeling
the interactions between the flow in the glomerular basement membrane and the
Bowman’s space with a boundary condition, the CFD simulation explicitly models
bulk flow in the Bowman’s space. One of the limitations of the current fluid flow model
is that it does not account for the effects of oncotic pressure, which was captured in
the previous work using the boundary condition coupling conditions in the glomerular
basement membrane and the Bowman’s space.
Boundary 2 is the inlet to the mesangium is a stagnation inlet with a pressure of
35 mmHg [23]. Boundary 3, opposite of boundary 2, is a symmetry plane. Boundary
1 is a no-slip wall representing the cell membrane of a mesangial cell. Boundaries
4 and 5 are the sides of the GBM and are symmetry planes. The undersides of the
podocytes are no-slip walls. In the Bowman’s space, the podocytes, including the
trimmed cavities in the inlet and outlet regions, are no-slip walls. The inlet, on the
left side of the Bowman’s space is a velocity inlet with a velocity of 392 µm/s. This
was estimated by dividing the average single-nephron glomerular filtration rate of a
healthy adult [70] by the average cross section area of the Bowman’s space [71]. The
outlet of the Bowman’s space is a pressure outlet with a pressure of 1.3 mmHg [23].
The surface on top of the Bowman’s space is a symmetry plane.
For each of the three regions, an automated meshing operation was used to create
a 2D quadrilateral mesh. In the Bowman’s space, the base size of the mesh is 0.1
µm, which is reduced to 0.01 µm near the tops of the foot processes. The top image
in Figure 2.6 shows the mesh generated in the Bowman’s space. In between the foot
processes, the base size is further reduced to 2.5 × 10−3 µm. Two prism layers are
used along the tops of the foot processes, and three layers are used along the sides of
the foot processes. The mesh surrounding the foot processes is the bottom image in
Figure 2.6.
In the glomerular basement membrane, the base size of the mesh is 5 × 10−3
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µm. Where the fluid exits the glomerular membrane into the Bowman’s space, the
base size is reduced to 2.5 × 10−3 µm (bottom image of Figure 2.6). Along the
underside of the foot processes, three prism layers are used. The mesangium uses
a base size of 5 × 10−3 µm as well and three prism layers along the bottom of the
mesangium. Figure 2.7 shows a representative portion of the mesh in the mesangium
and glomerular basement membrane.
Figure 2.6: The top image is an overview of the mesh generated in the Bowman’s
space. In the zoomed in region, the base size of the mesh is reduced between the foot
processes and in the glomerular basement membrane near the gaps.
A mesh independence study (not shown) was conducted to ensure a sufficiently
refined mesh was created. All sizes for each of the three meshes were reduced to 70%
of their original values. The average velocity of the fluid flowing through the gaps of
the podocytes at 0.1 µm above the glomerular basement membrane was measured.
The average velocity through the gaps was 0.974 µm/s on the base mesh and 0.978
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Figure 2.7: Representative regions of the mesh generated for both the glomerular
basement membrane and mesangium. Both regions use the same base size for most
of their volume.
µm/s on the refined mesh. The percent difference between the two meshes is 0.478%.
The resulting velocity field (Figure 2.8) was sampled and imported into the tissue
simulation as the field value for ~v in (2.6).
2.5 Simulation Results
2.5.1 Full Transport Model Results
Figure 2.9 shows the results of the entire transport model simulated within the Com-
puCell3D simulation. The artifacts in the glucose field are suspected to be related to
the meshing of the CFD simulation.
2.5.2 Podocyte Model Validation
A concern when incorporating the biochemical model of the podocytes into (2.6) is
that implementation differences in code between sources in (2.6) and their original
ODE form could may lead to appreciable differences in behavior. To ensure imple-
mentation differences did not affect simulation results of the models for both the
podocytes and the mesangium, we compared the results of the Python ODE and
PDE implementations of both models. To achieve this, the diffusion and convection
terms of (2.6) were removed, glucose was set to a fixed concentration in the simula-
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Figure 2.8: Velocity magnitude for the entire flow domain. The bottom image zooms
in on the mesangium, glomerular basement membrane, and between the foot pro-
cesses. The maximum velocity in the bottom image is set to 2 µm/s to highlight the
slow moving flow in this region.
tion space, and the simulation was run only allowing the PDEs to progress. We also
wanted to determine the effects of diffusive transport on the podocyte model. For this
case, diffusion of all species was allowed, including glucose, and the simulation was
run only allowing the PDEs to progress. Data was recorded from the center of mass







Figure 2.9: Concentration fields (mM) for each the CompuCell3D simulation including
all terms of (2.6). The bloodstream glucose concentration is set to 5 mM
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Figure 2.10: Difference of podocyte model behavior between model implementations.
The y-axes are the percent differences between the ODE and PDE implementations
using the ODE model as the basis. The x-axes are simulation time in hours. While
each simulation was run for 500 hours, the graphs generated only show a portion of
that simulation’s run. Each graph reports the difference as the average for all cells of
that type. Each line represents the average concentration of each species across all
podocytes in the simulation. In the diffusion and reaction case, the shaded regions
represent one standard deviation above and below the average.
Aside from a relatively small transient within the first 50 hours of each, the model
implementations appear to be in agreement in the reaction only case. Without con-
vection, the boundary conditions yields a glucose concentration very close to 5 mM
through out the simulation space. The small difference in the diffusion and reaction
case is not unexpected as a PDE of a well mixed system will have no appreciable
difference from an ODE model.
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2.5.3 Time Scale Analysis
An analysis of individual model component response to a step change in glucose was
conducted. For the diffusion of glucose, a simulation was run with only diffusion
enabled. After the first timestep, the blood glucose concentration was changed from
5 mM to 30 mM. Figure 2.11 has the results of this analysis. For the podocyte and
mesangial cell models, their ODE implementations were used to see their response to
an equal step change in local glucose (Figure 2.12). These processes were chosen to
contrast the responses of one of the fastest processes, glucose diffusion, to the slower
processes in the model.
Figure 2.11: The glucose concentration field response to step change in bloodstream
glucose. The bloodstream glucose steps from 5 mM to 30 mM. The time reported is
how long it takes for the concentration increase at that position to reach 95% of the
step size.
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Figure 2.12: The response of the podocyte and mesangial models to a step change in
bloodstream glucose. The y-axis is concentration normalized by the initial concen-
tration. The x-axis is time. The top image shows the response over 36 seconds. The
bottom image shows the response over 100 hours.
Out of the processes analyzed, the fastest is the diffusion of glucose, occurring on
timescales of micro to milliseconds. Reaction of ANG-I and ANG-II occur on time
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scales of seconds, and reactions of the rest of the species occur over hours. MMP-2 is
on the longest timescale, taking hundreds of hours to approach a steady state.
2.6 Conclusions
In the model’s current state, the solute transport model enables considering the effect
of space on cellular crosstalk. The tissue geometry has been coupled to the PDEs
through the convective and diffusive hinderance terms in (2.6). With the geometry
and transport coupled together, I have built a framework for connecting models of
kidney diseases progression from a healthy to diseased state.
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CHAPTER III
SBMLtoODEpy, An Open Source Systems Biology Markup Language to
Python Converter
3.1 Background
While working on Aim I, presented in Chapter II, I wanted to be able to include ar-
bitrary Systems Biology Markup Language (SBML) models as part of the multiscale
model. Adding the ability to incorporate SBML models into the virtual kidney will
help to expand the applications of the framework because SBML is an intermediary
language that facilitates exchanging biochemical reaction network models. A large
number of models are already developed into SBML documents. The largest repos-
itory of SBML models is the BioModels database [2, 3]. The BioModels database
is home to over 8,400 models from literature. These models have been submitted
directly by paper authors and database curators [3]. An additional 140,000 models
have been submitted to the Biomodels database from the Path2Models project, which
automatically generates models from metabolic data [72]. Not all of the models on
the BioModels database are curated. For the models that are curated, part of the
curation process involves annotating and ensuring correctness of models submitted
to the database. The guarantee of correctness means that the curated models may
be used to create a test suite for software developed to use SBML models [2]. The
large number of available models and ease of use makes incorporating existing SBML
models attractive.
SBML helps with model exchange by addressing three main problems. First, since
the language is not specific to a single software or simulator, its flexibility enables
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researchers to use diverse tools with varying strengths when developing or analyzing
a model. Second, by decoupling the model from the software used to build it, a model
no longer becomes obsolete if the software does. Third, standardizing how models are
defined reduces the confusion that may arise from a researcher working with another
researcher’s model [1].
While SBML is specifically designed for a wide variety of computational biology




x(t) = f(x(t),p) (3.1)
where x is the state vector of the model, and p is a vector of time-independent param-
eters” [73]. SBML is so flexible that even models of zombie infections developed with
variants of the susceptible infected removed epidemiology model have been described
using the standard [74].
The interoperability and usability of SBML is achieved by it being a declarative
language as opposed to an imperative language. This means that SBML merely
lays out the model components without explicitly implementing how to solve the
model. SBML leaves implementing and solving the model to the simulator or tool
of the researcher’s choice. Furthermore, a researcher need not focus on the details
of implementation when they have software previously developed to read, construct,
and solve SBML models [73].
SBML at its core is built upon Extensible Markup Language (XML) [1]. XML was
developed as a standardized way to store arbitrary data in a document that is human
and machine readable [75]. SBML builds upon the XML standard by implementing
standards for following model components [76, 77]:
• The SBML Container points to the appropriate XML namespace for the
SBML model based on the version and level of SBML used in the document. In
level 3 SBML, additional packages used to expand upon the base functionality
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are declared here.
• The Model object is located within the SBML Container and serves to
contain all other model elements. The base units used in the model may be
defined in the Model element.
• A Function Definition contains a single user-defined function. This function
is limited to only use other functions defined within the model and a subset of
MathML elements, such as arithmetic operators and logical operators.
• A Unit Definition allows a modeler to define units needed for their model
from a base set of units specified in the SBML specifications. Note that Unit
Definitions are completely optional, and SBML does not specify or require a
check for unit consistency in a model. It is up to the modeler or the software
to ensure units are explicitly accounted for and consistent in their model.
• A Compartment represents an arbitrary space in which a Species exists.
Compartments need not be three dimensional; a surface may be represented
by a two-dimensional Compartment. SBML level 3 even supports Compart-
ments with fractional dimensions. Just like with Unit Definitions, SBML
does not check for unit consistency with respect to Compartment dimension-
ality.
• A Species represents “a pool of entities that (a) are considered indistinguish-
able from each other for the purposes of the model, (b) may participate in
Reactions, and (c) are located in a specific Compartment” [76]. This is a
more abstract implementation of a chemical species, and can represent anything
that fits the above requirements. For example, a population of rabbits can be
a Species in a population model represented in SBML.
• A Parameter is simply intended to be a value with an identifier. Parameters
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can be set to be constant or used as variables in your model. Additionally,
Parameters can have units associated with them, without any unit consistency
checks.
• An Initial Assignment is an optional way to set any value of a model at t ≤ 0.
Each value may have an initial value specified, but an Initial Assignment
allows for a value to be set based on a calculation instead of a specified value.
• Rules are used to provide additional ways to compute variable values in a
model.
– An Algebraic Rule represents an equation of the form
0 = a+ b+ c+ . . .+ z (3.2)
where a through z represent an arbitrary number of model values. Each
value is calculated as appropriate to satisfy the Rule. SBML provides a
set of rules that specifies which variables may not be determined by an
Algebraic Rule.
– An Assignment Rule represents an equation of the form
a = b+ c+ . . .+ z. (3.3)
While the mathematical forms of Algebraic and Assignment Rules are
equivalent in the abstract, they are handled differently. In an Assignment
Rule, it is assumed that the right hand side of the equation may be used
to directly calculate the value of a.
– A Rate Rule represents an equation of the form
d(a)
dt
= b+ c+ . . .+ z. (3.4)
37
The Rate Rule is similar to an Assignment Rule. The Rate Rule is
integrated to directly assign the value of a.
• A Constraint defines the assumptions that a model is valid under. A Con-
straint comprises of a math term that determines if the Constraint is satisfied
or not and a message that is displayed to the user if the Constraint is no longer
satisfied.
• A Reaction is “any kind of process that can change the quantity of one or
more Species in a model” [76]. Similar to a Species component, a Reaction
is an abstract implementation of a chemical reaction. As such, a Reaction
can represent any process that is appropriate to the model, including transport
from one Compartment to another.
• An Event is an instantaneous effect on the model. Events are comprised of a
Trigger, an optional Delay, an optional Priority, and a list of assignments that
perturbs the model state.
All of these components are supported by SBML level 3, which has the greatest
number of features [76]. Each iteration of the SBML standard is denoted by a version
and level. Each level represents a increase in features compared to the previous
level, while each version is a refinement of the previous version of that level. The
three different levels of SBML are continuously developed and are intended to serve
a continual purpose [77, 78].
The simulator of use in Aim I is Compucell3D. Compucell3D supports implement-
ing custom Python [4] scripts that can determine cell behaviors [48]. Incorporated
into Compucell3D is libRoadRunner, an SBML model simulator. A key strength of
libRoadRunner is that it compiles an SBML model directly into machine code [73].
As a result, the implemented model is simulated very efficiently, but this implemen-
tation is mostly immutable. Changing the functionality of a model during runtime
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has been useful in my research for model analysis [6]. As a result, the immutability
of an SBML model implemented by libRoadRunner is a negative that outweighs the
benefits of faster execution.
Another tool useful to researchers who want to implement SBML models is the
Systems Biology Format Converter (SBFC). SBFC is directly integrated into the
Biomodels database and is used to automatically convert SBML models into the full
range of formats it supports [5]. The Octave implementations generated by SBFC are
scripts that simply initialize and simulate the model for a certain duration. These
scripts do not take advantage of programming concepts like object oriented program-
ming, which would reduce developer time needed to incorporate these models. At the
time of writing, SBFC does not support Python.
Other tools exist for working with SBML models, such as COPASI or libSBMLsim,
but most tools developed for working with SBML were not designed to be directly
integrated into other programs [73].
3.2 Software Details
The work presented in this section includes sections of the paper, code, and documen-
tation that have been peer reviewed and published in [79]. My contributions to this
work include designing and writing the code and writing the application programming
interface documentation.
3.2.1 Summary
The goal of this aim is to develop a Python package called SBMLtoODEpy to address
the limitations detailed in earlier sections by enabling conversion of SBML models into
Python classes that can be rapidly incorporated into biomedical systems modeling
projects written in Python, such as the project described in Aim I, or used directly
in Python. SBMLtoODEpy generates code that uses object oriented programming
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to create code that users can write their own code to interface with. The program
aims to accelerate construction of multiscale models that import and reuse published
SBML models.
In SBMLtoODEpy, each of the model components are extracted using libSBML.
LibSBML is a key tool that helps support SBML. It is a software library that has an
application programming interface that simplifies reading and editing SBML docu-
ments [78]. The model components can be output to a JavaScript Object Notation
(JSON) file. JSON is a format that is easier for users to read and directly edit than
either the SBML or Python implementations of the model. The extracted model
components are used to create a Python file that defines a class that implements
the model. A method for the class is generated to solve the model using a wrap-
per for the LSODA algorithm in the SciPy Python package [80], and the NumPy
Python package [81] is also used. To verify that SBMLtoODEpy properly interprets
SBML files and converts them into functional differential equations models, we com-
pared the results of SBMLtoODEpy with COPASI, a graphical user interface based
platform for simulating SBML models [82], for a set of representative SBML files
downloaded from the BioModels Database that were deposited for a selection of sys-
tems biology publications [83, 84, 85, 86, 87, 88]. This comparison served purely
to verify that SBMLtoODEpy was properly setting up the equations for the model
as both COPASI and SBMLtoODEpy rely on ODEPACK to solve differential equa-
tions [89]. These files have been included in the SBMLtoODEpy package within the
sbmltoodepy/sbml files subdirectory to serve as examples for users.
The code is split into three main roles. The first is the algorithm that uses libS-
BML to extract the model components from the SBML document. At this point, the
extracted data can either be saved to a JSON file or passed to the second algorithm of
the package. The second algorithm takes the extracted model components and writes
the Python class to a file. This includes ordering Assignment Rules such that none
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of the Rules use undefined values and constructing the system of differential equa-
tions that arise from the Reactions and Rate Rules of the model. SBMLtoODEpy
represents the ODEs as
d
dt
s = Aξ(s) + r(s) (3.5)
where s is a vector representing the model state, A is a matrix of stoichiometric
coefficients, ξ is a vector containing the extents of reaction, and r is a vector containing
the rates of change determined by Rate Rules. Figure 3.1 illustrates the roles of
these algorithms.
Figure 3.1: The two algorithms implemented in the SBMLtoODEpy package are
represented as the two sets of arrows. The first algorithm parses the components of
the SBML model (filled boxes) and stores the results. The second algorithm defines
Python classes and defines methods to solve the model numerically.
.
The third portion of the code includes the classes and functions that help im-
plement specific features of SBML components, such as Compartments and Pa-
rameters. This includes methods that prevent modifying values that are flagged as




3.3.1 Interactive Jupyter Notebook
An interactive Jupyter notebook working through the installation and a couple of
examples can be found at https://github.com/SMRuggiero/sbmltoodepy/blob/
master/SBMLtoODEpy.ipynb?short_path=948bbb4
An online version that does not require installation of Python can be found at
https://colab.research.google.com/drive/1yBscTNFwgliOUD10YhdWh-3HvXdj1YUF
3.3.2 Creating a Python Model
The fastest way to create a Python model using SBMLtoODEpy is to open a Python
interpreter in the same folder as the SBML file. Then, run the following lines of
Python code using the name of your model.
import sbmltoodepy
sbmltoodepy.ParseAndCreateModel("YourModelNameHere.xml")
If no errors occur, then a file with the same name as the SBML file but with the
extension .py will be created in the same folder. To have a file created with a different
name, you can use the outputFilePath keyword argument.
sbmltoodepy.ParseAndCreateModel("YourModelNameHere.xml",
outputFilePath = "PythonFile.py")
The new Python module defines a class named SBMLmodel. To customize the




The last optional keyword argument of ParseAndCreateModel() is jsonFilePath.
If specified, a JSON file containing all of the model elements parsed from the SBML
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model will be created.
sbmltoodepy.ParseAndCreateModel("YourModelNameHere.xml",
jsonFilePath = "YourModelNameHere.
json", outputFilePath = "
PythonFile.py", className = "
ModelName")
In reality, creating a Python model with SBMLtoODEpy is a two step process




py", objectName = "ModelName")
The function ParseAndCreateModel serves as a wrapper for two other functions,
ParseSBMLFile and GenerateModel. ParseSBMLFile returns an instance of the Mod-
elData class with all of the components pulled from the model. While you can use that
instance as input to GenerateModel, there is another feature of SBMLtoODEpy that
the ModelData class provides. The ModelData class has a method, DumpToJSON,
that generates a JSON file with the model components.
sbmltoodepy.dataclasses.ModelData.DumpToJSON(dataOfModel ,"
YourModelNameHere.json")
A JSON file created from the DumpToJSON method can be used a create a new
instance of the ModelData class.
newInstance = sbmltoodepy.dataclasses.ModelData.LoadFromJSON("
YourModelNameHere.json")
A possible use case for this would be to generate a JSON file from an SBML
model, change the JSON file, which is more human readable than an SBML file, and
use the changed JSON file to create the Python model.
43
3.3.3 Exploring a Newly Created Python Model
After generating the Python implementation of a model, you can now import the new
class and instantiate it.
from PythonFile import ModelName
modelInstance = ModelName ()
The main components that make up the state of an SBML are Compartments,
Parameters, and Species. Each of these are stored in a dictionary that is a member
of the model class. These members are named c, p, and s respectively. The key
for each dictionary entry is the “id”, as defined by the SBML specification, for the
component. By printing one of these dictionaries keys, you can see the id of each
Compartment, Parameter, or Species.
# get the dictionary keys for the IDs of the species in the model
print(modelInstance.s.keys())
# get the dictionary keys for the IDs of the compartments in the
model
print(modelInstance.c.keys())
# get the dictionary keys for the IDs of the parameters in the model
print(modelInstance.p.keys())
The individual model elements are represented as instances of an appropriate
class. Parameters are instances of the Parameter class, and the value member
contains the Parameter’s value. Species are instances of the Species class, and
the concentration and amount members are used in calculations. Compartments
are instances of the Compartment class, and the size member contains the size of the
Compartment.
# replace compartmentId with one of the dictionary keys returned
from print(modelInstance.c.keys())
print(modelInstance.c[’compartmentId ’].size)








Function Definitions and Reactions are stored in a similar manner. Currently,
Rules and Initial Assignments are not handled the same way. Rate Rules are
bound methods of the model class that are called alongside Reactions, and Assign-
ment Rules and Initial Assignments are implemented through a method of the
model class, AssignmentRules(). Algebraic Rules are not completely supported
currently.
In SBML, each model component can have both an id and a name, but only the
id is required. Each of the dictionaries containing Compartments, Parameters,
Species, Reactions, and Function Definitions can be searched by the component
name using the appropriate method. Note that the original model must not have
a blank metadata field for the corresponding entry for the search by name to yield
any results. In SBML, there is no guarantee that names are unique (each component
in a model does have a unique id). If a single component matches, a list with the
component’s id and object is returned. If multiple components match, then a nested
list is returned. Each element in the list is a list with a component’s id and object.
Lastly, if no match is found, the behavior of the function depends on the keyward
argument suppress. If suppress is False, an exception is raised. If suppress is True,
then an empty list is returned.





modelInstance.SearchSpeciesByName(’species name’, suppress = False)
modelInstance.SearchReactionsByName(’reaction name’, suppress =
False)
modelInstance.SearchFunctionsByName(’function name’, suppress =
False)
The last part of the model’s state is simulation time; the current simulation time
is stored in the time member of the class. The unit of time in the model is treated as
arbitrary by the package. The unit for time is dependent on the units of parameters
set by the modeler. This package does not check if the units in a model are consistent.
print(modelInstance.time)
3.3.4 Simulating the Model
The RunSimulation() method is used to step the ODE model forward in time by
timeinterval. The method updates the value of each model component and the total
elapsed simulation time over all calls to RunSimulation.
modelInstance.RunSimulation(timeinterval)
There are two optional keyword arguments, absoluteTolerance and relativeToler-
ance, which are for tuning the tolerances used to solve the ODE model with LSODA.
modelInstance.RunSimulation(timeinterval , absoluteTolerance = 1e-12,
relativeTolerance = 1e-6)
An important thing to note is that the model only keeps values for the current
time. If you wish to graph the evolution of a Species with respect to time, the
concentration and time will need to be sampled at the appropriate time points.





concentrations[0] = modelInstance.s[’speciesId ’].concentration
timeinterval = 1
for i in range(100):
modelInstance.RunSimulation(timeinterval)
times[i+1] = modelInstance.time
concentrations[i+1] = modelInstance.s[’speciesId ’].concentration
The results can then be graphed using any method you would like. For graphing
directly in python, matplotlib is a good option.
import matplotlib.pyplot as plt
plt.plot(times ,concentrations)
3.4 Conclusion
SBMLtoODEpy was designed to be extremely researcher friendly; researchers are able
to convert models with a single function call. Even within a single Python script,
a user can convert a model and import it immediately during runtime. The code
and documentations are the peer reviewed products of this work. The project is open
source and may be freely edited and redistributed. The source code can be pulled from
https://github.com/SMRuggiero/sbmltoodepy/tree/master/sbmltoodepy/sbml_
files [90] in addition to PiPy. SBMLtoODEpy has already been incorporated into
my work. In the virtual kidney project described in Chapter II, I instantiated 255




Procedural Generation Methods in Tissue Simulation
4.1 Background
4.1.1 Procedural Content Generation
Procedural content generation (PCG) broadly refers to the programmatic creation
of game elements. These elements include, but are not limited to, maps, items,
characters, graphical elements, and music within the game [91]. One of the earliest
games that made heavy use of PCG is the 1984 cult classic Rogue. Rogue places you
in the shoes of a novice adventurer delving into a dungeon. If your character dies, the
game ends, and you must restart from the beginning. The catch: since the procedural
generation used by Rogue to create each floor of the dungeon is random, the layouts
of the floors are new each time you play [92]. Figure 4.1 shows the first level from
Rogue from two separate attempts.
In their 2013 submission to The Fourth Procedural Content Generation in Games
workshop, Compton, Osborn, and Mateas proposed coining the titular term “genera-
tive methods” as an umbrella that includes PCG along with other analogous methods
from other fields [93]. The working definition proposed for generative methods is “a
function which produces artifacts” where an artifact has a structure and a context.
If we take a generative method that produces figures in the form of a picture as an
example, the figure is the artifact, how the pixels are encoded is the structure, and
the article that the figure is in is the context. The primary argument for using the
term generative method is to increase the academic visibility of PCG research and
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Figure 4.1: Two separate versions of the first level of the game Rogue [92]. Each of
the game’s elements are represented by a character of text. The brown borders and
green periods represent the walls and interior space of rooms, respectively. The gray
shaded areas are hallways. The player is the yellow face character, and enemies are
represented by gray capital letters: B for a bat in the top image and E for an emu
in the bottom image. The stairs going deeper into the dungeon are represented by a
flashing ≡ with a green background.
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to continue the cross pollination of ideas between fields [93]. PCG borrows solutions
from the fields of “AI, computational intelligence, computer graphics, modeling, and
discrete mathematics” [94]. Compton, Osborn, and Mateas argue that advances in
PCG have little academic visibility to other fields despite the presence of similar
techniques in art, architecture, computer aided design, optimization, and more [93].
Within engineering, there are techniques that fit the definition of a generative
method. A broad range of engineering challenges from logistics to reactor design can
be viewed through the lens of designing a set of problem relevant parameters to find
the best design. Using this lens, the task can distilled down into an optimization
problem [95]. When solving an optimization problem, an algorithm searches a design
space to produce a parameter set that yields an optimal solution [96]. The output of
this algorithm has a structure, typically a list of parameter values, and a context, the
model used in the optimization problem. In other words, optimization techniques fit
the definition of a generative method.
Genetic algorithms are a class of global optimization techniques that attempt to
solve an optimization problem by conceptualizing a models parameter as genes in
a genome. A genetic algorithm puts a population of trial parameter sets through
a process of mimicing mutation, recombination, and natural selection. Populations
start across an wide area of the design space and narrow towards the best optima
encountered [97, 96, 98, 91, 99]. Two examples of problems that can be solved by
genetic algorithms are scheduling and transportation problems [99]. In the context of
biomedical engineering, genetic algorithms have shown success in fitting quasi-linear
viscoelatic models [100] to data generated from a wide variety of soft tissues [101, 102].
Not only are genetic and evolutionary algorithms good choices for engineering
problems with a high number of local minima, they are the methods of choice for
search-based PCG [91]. One use case of search-based PCG is the generation of tracks
of a racing game tuned to a specific player [103]. In this case, core information for
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producing a track is represented as a series of waypoints that form a closed loop. The
generator produces the tracks from these waypoints by drawing curves on either side
of the loop. Figure 4.2 shows two generated tracks and their waypoints.
Figure 4.2: Two example tracks generated by the method presented in [103]. These
examples were generated based on the play style of one of the authors and serve as an
example of the same method producing individualized content for different players.
A model of the player is then used to simulate how the player might perform on the
track. The track was evaluated on the model player’s progress on the track, variance
across trials, and maximum speed achieved on the track. Starting from a random set
of points, the optimization algorithm used was able to design tracks specifically for a
single player [103].
4.1.2 Motivation
In an early stage of the DKD research presented in Chapter II, the focus was on
examining the effects of cellular dysfunction at the level of an entire glomerulus. To
this end we prepared simulations of the cross section of the glomerulus in Compu-
Cell3D [48]. For background information on DKD and CompuCell3D please refer to
Chapter II. Figure 4.3 served as a reference for developing the starting point for our
early simulations as seen in Figure 4.4.
However, looking at the structure of an actual glomerulus (Figure 4.5), questions
about how best to capture the cross section arise. The actual structure of a glomerulus
is highly irregular; cross sections of different glomeruli will have varying numbers of
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Figure 4.3: An illustrated cross section of a glomerulus adapted from [16]. This
illustration served as an initial reference for the first set of initial conditions created.
Figure 4.4: The earliest simulation initial conditions that had the capillaries (red)
placed and podocytes (blue) properly enveloping the mesangium (green) and capil-
laries.
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capillaries, variance in the positioning of capillaries, differences in the volume of the
mesangium relative to the surface, etc. Since patients have thousands of glomeruli
and we expect that the structural failure of the glomerulus is directly affected by
the structure itself, we need to be able to simulate starting from a variety of initial
structures.
Figure 4.5: Microscopy and 3D reconstructions of renal tissue sampled from patients
with mid stage kidney disease without other complications [104]. The spherical struc-
tures in both images are glomeruli. The cross sections and surfaces of glomeruli are
highly variable but do have patterns.
4.1.3 Methods Used in Literature
CompuCell3D provides some rudimentary functions to researchers [55], but the com-
mon ways of initializing CompuCell3D simulations are to use CellDraw, a tool pack-
aged with CompuCell3D, or to sweep through the pixels of the simulation space and
to draw cell objects based on coordinates.
CellDraw provides a graphical user interface for drawing the initial conditions of
a simulation. It takes the completed drawing and converts it into a plain text format
that contains position data for each cell [54]. The main advantage of CellDraw is that
it allows a researcher to develop a complicated tissue structure as a starting point
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for their simulation with minimal programming knowledge necessary. Its biggest
drawback is the large amount of researcher time needed to develop a single starting
geometry. Due to the programming knowledge that was expected to be necessary in
developing the glomerular simulations, the large number of geometries needed, and
the burden on the user’s drawing ability, CellDraw was determined to not be a great
fit for the project.
Sweeping through all of the pixels in the simulation space has its own set of
strengths and weaknesses. Typically the code sweeps along each axis of the sim-
ulation space and places cells at each pixel by running a set of calculations. The
primary strength is the high level of precision the developer has over the resulting
geometry. This method can also be parameterized, allowing the resulting geometry
to be tweaked by changing variables and leaving the rest of the code unchanged.
But parameterization of this method has severe diminishing returns. As a developer
seeks to introduce more complex ways to parameterize their simulation geometry,
the resulting code complexity outpaces the complexity introduced into the starting
geometry.
As an example, consider placing a podocyte cell one pixel below a capillary, or
one pixel lower along the y-axis in the convention of CompuCell3D. Assume that the
placement of the capillary has been parameterized as well. If we choose parameters
to place a capillary at (2, 2), we will place a podocyte at (2, 1). If we start our sweeps
from (0, 0), (2, 1) will be visited first, regardless of which axis is looped along first, and
the capillary will not been placed at (2, 2) yet. Of course, the simplest approach is
to reverse the direction the y-axis is iterated along. Swapping the y-axis works here,
but this is a simplified version of a problem encountered in developing the initial
conditions for the glomerular simulations. The actual problem is placing podocytes
along the surface of the capillary not in contact with the mesangium, which requires
placement above and below the capillary.
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A seemingly straight forward approach to consider is checking if a capillary will be
placed at (2, 2). Since the placement of the capillary itself has been parameterized,
the check at (2, 2) can be as computationally complex as the check in the current
pixel. This alone does not make writing of the code considerably more complex.
Assuming that checking the pixel is its own function, the researcher could just call
the function at (x, y) and (x, y+ 1). However, parameterizing both the podocyte and
capillary can create interactions. Since the capillary is parameterized, its placement
might depend on checking the pixel above or to the right of it. Since we started from
placing a podocyte relative to an object that has a location that is parameterized,
all of these extra checks will need to be done at every pixel visit that could possibly
allow a podocyte and not just a specific location. An approach that avoids chaining
checks would be to simply sweep through the simulation space twice and place the
podocytes on the second pass. The issue is that the same interaction that causes
chaining multiple checks leads to needing multiple sets of loops through the entire
simulation space.
Looping through the simulation space is attractive because CompuCell3D stores
the cell locations in a three-dimensional array, and a nest of three loops is a logical
way to access every element. However, we do not actually need or want to visit every
element; not every pixel is occupied by a cell. If we resolve where all the cells are
before actually placing them, we can skip over the empty elements. Therefore, the
starting point for developing our simulation geometry combined conceptual aspects
of CellDraw and the method of programmatically evaluating what cell goes in a pixel
based on its coordinates.
One method from literature on a different scale of systems biology simulation
involved generating the structure of a cell or tissue using a generative model [105, 106,
107]. In the context of machine learning, a generative model is trained to estimate
the probability distribution of a population [108]. The generative models used in
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these methods predict the distribution by producing simulacra of individuals of the
population. In these cases it is the simulacra themselves that are useful [106]. These
models are trained using massive amounts of data of the population they are trying to
generate, typically in the form of annotated microscopy [105, 106, 107]. While data
sets containing microscopy of glomeruli are available [109], and machine learning
has been applied to studying glomeruli [110], a data set with the level of annotation
needed for our purposes is not available. Further, we do not seek to recreate images of
glomeruli, we are trying to create a representation that may be used in CompuCell3D.
4.2 Generation of Cellular Geometry
4.2.1 Glomerulus Cross Sections
We wanted the ability to statistically sample a population of geometries, produce the
geometry rapidly for each simulation, thoroughly parameterize how the cross sections
are laid out, and do all of this without the data useful to train a generative model.
Inspired by the level generation of games like Rogue [92], an algorithm was developed
to generate the cross section of the glomerulus as if drawing part of a level. The
algorithm places the cells in our simulation by computing the location of each cell
and the exact pixels the cell occupies, and then “paints” them to the array of cells
by writing to all elements the cell occupies. Painting the glomerulus was done in four
steps. Figure 4.6 shows the geometry after each of the steps.
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Step One: Mesangium Step Two: Podocytes
Step Three: Capillaries Step Four: Capillary Podocytes
Figure 4.6: The simulation initial geometry after each step of the algorithm.
The first step starts by drawing in the mesangium. The method CreateBlob()
uses the ratio of the mesangium diameter to cell width to calculate a circle diameter.
If a diameter of 50 and cell width of 5 is chosen, the resulting circle diameter is 10.
Using the midpoint algorithm [111], CreateBlob() calculates the points of the circle
and optionally fills the circle in. For the mesangium, this circle is filled in. The pixels
of the circle are mapped to a cell width by cell width square section of the simulation
space, where a cell is drawn for every pixel. To add in the initial set of podocytes,
CreateBlob() is called again with the fill option disabled. This overwrites the outer
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most layer of mesangial cells with podocytes.
The next step is placement of the capillaries. The CreateCapillaries() method
identifies evenly spaced points in a circle around the center of the glomerulus. At
each of those points, it creates a large circular cell in that position using the midpoint
algorithm. In this case, instead of expanding the circle to draw multiple cells, the
pixels are mapped directly to the simulation space to draw a single cell. This method
can also evenly place the capillaries in a specified segment of the circle around the
mesangium.
The last step has two parts. The PlacePodocytesAroundCapillaries() method
starts by cleaning up after the CreateCapillaries(). An unintended consequence
of CreateCapillaries() is that podocytes end up between capillaries and mesangial
cells. For each capillary, PlacePodocytesAroundCapillaries() finds its neighboring
cells and forces them to be mesangial cells. The method then finds the portion of
each cell’s border in contact with the medium. This exposed region is patched over
with a single podocyte cell that is grown outwards in layers one pixel thick. The giant
podocyte cell is split up into smaller chunks of a volume similar to the cells placed
with the CreateBlob() function.
The final version of the algorithm has nine different parameters that can be ad-
justed to change how the geometry is generated. Examples of geometry produced
after parameterizing this procedure are in Figure 4.7. The procedure makes several
assumptions about how the cells are placed in relation to each other. These assump-
tions limit the amount of variability of the geometries produced by the procedure. As
a result, I sought to generalize producing the geometry further.
4.2.2 Generalizing the Algorithm
The approach proposed in this section to generalize the generation of simulation
geometry is based on the method used to generate outdoor maps in the game Path
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Figure 4.7: Simulations of procedurally generated glomeruli in the preliminary results
for Aim II. In the left column, the capillaries are evenly spaced along the entire outside
of the mesangium. The right column has an arc at the top excluded, and the capillaries
are placed evenly along the included arc. The five capillary case with an excluded
arc (bottom right) mimics the glomerulus of Figure 4.3.
of Exile [112]. Just like in Rogue [92], Path of Exile uses procedural generation to
create the map of every playable area of the game. Unlike Rogue, Path of Exile uses
its method to create variants of the same layout instead of completely randomized
layouts. Each area may have more than one layout, but each time a map is created
from the same layout, the key objectives are placed in the same general area.
Each layout is represented as a graph. A graph is an abstract network of nodes
and edges, and the nodes and edges together represent how objects of a network are
connected. Figure 4.8 is an example of one of these graphs and a map generated from
it. Nodes are used represent key locations of the area such as exits, story objectives,
or intersections. The edges are the paths between these locations and have types
associated with them that determine the terrain that make up the paths, including
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rivers that cannot normally be walked over. Since the edges are straight lines, nodes
can also be used to indicate a bend in the path. The regions are filled in automatically
based on the typing of the edges enclosing it [113].
Figure 4.8: An overhead view of a playable area in Path of Exile [112] and the graph
used to represent the area’s layout presented in [113].
The terrain is built up by piecing together tiles. The tiles are square or rectangular
portions of terrain that have been modeled by an artist. These tiles can be manually
arranged into “rooms”, which can be prearranged tiles of an outdoor area. Typically
rooms are used for the locations denoted by the nodes of the graph but can be included
as interesting features dispersed through the map [113].
To translate the preceding discussion about Path of Exile to constructing geome-
tries for our simulation, each of the elements need to be redefined in terms of drawing
cells. The graph itself is an abstract representation of the tissue structure. The nodes
of the graph represent key features of the tissue or reference points for edges. The
edges represent the cells connecting the key features, or thin features of the tissue,
such as the glomerular basement membrane. The idea of treating the cells as tiles
and puzzling them together is less relevant. The tiles that make up the maps of Path
of Exile need special consideration so the edges of each tile match up, allowing the
terrain to remain continuous from tile to tile [113]. Instead of placing individual cells
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as tiles, painting functions can be used to place cells. The concept of “rooms” is still
useful, as manually arranged cells or custom painting functions allows for complex
features. An example of a “room” in the glomerulus cross section is the function
written to place capillaries and the podocytes around them. A useful extension of
this method is to directly consider the regions of the graph. Instead of filling the
regions based on the surrounding edges, a generalized painting function can be used
to fill the region in with cells.
4.3 Conclusions
The algorithm incorporated into the glomerular tissue simulation is able to produce
a variety of geometries useful for on whole glomerulus scale simulations. There are
nine parameters in the code that may be adjusted to vary the geometry produced.
However, even the current alogrithm is limited in the geometries it can produce. This
method may be generalized to produce varied geometries from an arbitrary graph.
This generalized algorithm may be a useful tool for other researchers developing




Recommendations for Future Work
5.1 Aim I: Establishing the Virtual Kidney
One effect that the transport model neglects is the effect of oncotic pressure on fluid
flow. Modeling oncotic pressure requires coupling the solute transport to the CFD
simulation. Directly coupling the Star-CCM+ [69] simulation with the CompuCell3D
simulation was considerd, but Star-CCM+’s application programming interface made
this too onerous of a task. OpenFOAM [115] is a CFD simulator that seems promising
to incorporate into the virtual kidney project as an alternative to Star-CCM+.
Using the mesangial model to define solute concentrations in the bloodstream was
a stopgap used to produce results that showcased the behavior of the transport model.
Using a global renin-angiotensin system model for the bloodstream is recommended.
My work on the tissue model left off at designing the tissue geometry at the
start of the simulation. The next step is to model the normal behavior of the cells,
how the biochemical and transport models disrupts the cells’ behavior, and how this
propagates to the structural changes that result from cross talk.
5.2 Aim II: SBMLtoODEpy, An Open Source Systems Biology Markup
Language to Python Converter
SBMLtoODEpy currently does not support Events and Constraints. The next
major version update to the package should include supporting these model elements.
These additions are on top of the regular maintenance expected as libSBML [78] and
the SBML specifications [1] are routinely updated.
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5.3 Aim III: Procedural Generation Methods in Tissue Simulation
While a prototype for the generalized algorithm presented in Aim III was started,
Aim I diverged from the need for this prototype. Aim I was prioritized and grew to
be time demanding to finish the prototype. Continuing this work require developing
the prototype into functional software.
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Podocyte and Mesangial Cell Models
The work presented in this chapter Dr. Minu Pilvankar’s podocyte model [47] and
Ashlea Sartin’s model of TGF-β1 and MMP-2 regulation in the mesangial cell. These
are the biochemical models incorporated into the work presented in ChapterII.
The mass balance for AGT is
d[AGT]
dt




where kAGT is the constant production rate of AGT, cRenin is the glucose-dependent
rate parameter for renin-catalyzed conversion of AGT to ANG I, and hAGT is the
half-life for the degradation of AGT [46].
The mass balance for renin is
d[Renin]
dt
= sRenin + kf ([ANG II]0 − [ANG II])
(







where sRenin is the constant source of renin in the absence of feedback, the second
term is the influence of ANG II negative feedback on renin production, [ANG II]0 is
the initial concentration of ANG II, kf and f are parameters for the feedback, and
hRenin is the half-life for the degradation of renin [116]. The renin source term is





where [Renin]0 is the initial concentration of renin [116].
The mass balance for ANG I is
d[ANG I]
dt
= cRenin[AGT] + kRenin([Renin]− [Renin]0)− cACE[ANG I]





where the first term represents the glucose-dependent renin-catalyzed contribution
to the production of ANG I from AGT, the second term represents the change to
ANG I synthesis from AGT due to the feedback of ANG II on renin with rate constant
kRenin, the third term is the ACE-catalyzed conversion of ANG I to ANG II that has a
glucose-dependent rate parameter cACE, the fourth term is the consumption of ANG I
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to form ANG-(1-7) and ANG-(1-9) with the glucose-independent rate parameters
kNEP and kACE2, respectively, and hANG I is the half-life for the degradation of ANG I.
The first and second terms in (1.4) both consider the production of ANG I from AGT
catalyzed by renin. The first term is from glucoseRASpodocytes and includes glucose
dependence in the absence of the ANG II-renin feedback mechanism. The second
term is from ACEInhibPKPD to incorporate the effects of the feedback mechanism
on changing the production rate [46, 116].
The mass balance for ANG II is
d[ANG II]
dt





where the first term is the production of ANG II in the presence of ACE that is
subject to inhibition I by the drug; the second term is the consumption of ANG II as
it converts into downstream peptides and binds to AT1 and AT2 receptors; cAT1 is the
glucose-dependent rate parameter for binding of ANG II to AT1 receptor; kAT2, kAPA,
and kACE2 are the glucose-independent rate parameters for binding of ANG II to the
AT2 receptor and conversion of ANG II to ANG III and ANG-(1-7), respectively;
and hANG II is the half-life for degradation of ANG II [46, 116].
Glucose dependency is included in the parameters designated by cx, where x =
Renin, ACE, and AT1. In glucoseRASpodocytes [46] these parameters were found
to be the most sensitive and were each considered to be a linear function of glucose.
The glucose-dependent parameters are calculated using [46]
cRenin = aRenin[GLU] + bRenin (1.6)
cACE = aACE[GLU] + bACE (1.7)
cAT1 = aAT1[GLU] + bAT1 (1.8)
where [GLU] is the concentration of glucose and the coefficients ax and bx in (1.6)–(1.8)
are obtained from parameter estimation detailed in [46].
TGF-β production is upregulated by an increase in the concentration of an-





([ANGII]− [ANGII]NG) + a1
− kT [TGF] (1.9)
where [TGF] is the concentration of TGF-β, BT is the baseline production rate of
TGF-β, k1 is the rate constant of angiotensin II stimulated production of TGF-β,
[ANGII]NG is the concentration of Angiotensin-II at normal glucose levels, a2 is the






Table A.1: Pharmacodynamic parameter values for the podocyte local RAS model.
Parameter Value Units Sources
kAGT 2.27× 106 nmol/L/h [46]









hAGT 10.0 h [46, 117]
hRenin 0.250 h [116]
hANG I 1.72× 10−4 h [46, 117]
hANG II 5.00× 10−3 h [46, 117]
aRenin 5.47× 10−4 L/mmol/h [46]
bRenin 6.14× 10−2 h−1 [46]
aACE 0.889 L/mmol/h [46]
bACE 16.3 h
−1 [46]
aAT1 2.55 L/mmol/h [46]
bAT1 46.4 h
−1 [46]
kf 4.92× 10−5 h−1 [116]
f 5.05× 10−4 nmol/L [116]
[AGT]0 1.70× 104 nmol/L [46]
[Renin]0 2.06× 10−4 nmol/L [116]
[ANG I]0 0.271 nmol/L [46]
[ANG II]0 2.10× 10−2 nmol/L [46]
[ANG II]0, sys NRF 1.65× 10−2 nmol/L [116]
[ANG II]0, sys IRF 2.05× 10−2 nmol/L [116]
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where hT is the half-life of TGF-β. BT is defined as
BT = kT [TGF]NG (1.11)
where [TGF]NG is the concentration of TGF-β at normal glucose levels.








where [MMP] is the concentration of MMP, BM is the baseline production rate of
MMP, k2 is the rate constant of TGF-β inhibited MMP production, a2 is the half-





where hM is the half-life of MMP. BM is defined as




where [MMP]NG is the concentration of MMP at normal glucose levels.
Table A.2: Parameters for equations (1.9) and (1.12).
Parameter Value Units Sources
BT 4.55 ∗ 10−4 mmol/L/h -
k1 3.18 ∗ 10−2 mmol/L/h -
a1 1.08 ∗ 10−5 mmol/L -
kT 0.462 h
−1 -
hT 1.5 h [44]
BM 4.55 ∗ 10−4 mmol/L/h -
k2 3.70 ∗ 10−6 mmol2/L2/h -
a2 −2.04 ∗ 10−2 mmol/L -
kM 1.51 ∗ 10−2 h−1 -
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